Global tungsten markets returning to growth

Published 16-APR-2019 12:26 P.M.

|

6 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

It has been tungsten’s turn to top the news flow in the last week with Reuters reporting important developments in relation to ASX listed group’s Apollo Minerals Ltd (ASX:AON) and King Island Scheelite Ltd (ASX:KIS).

There have also been some strong share price performances outside those two companies since March with shares in Specialty Metals International Ltd (ASX:SEI) increasing 50% in March.

Granted, rampaging iron ore and oil prices have recently dominated global headlines, but this strategic commodity with very little potential substitution has been out of the news for some 12 months, arguably adding prominence to recent events.

Roskill, a notable industry source in terms of analysing specialty metals noted last year that global tungsten markets were returning to growth following several years of oversupply and low prices.

Supply issues for world’s largest consumer

In a 10 year outlook statement, Roskill said, “Tungsten market fundamentals have changed as demand from defence, industrial, and oil and gas applications has picked up, just as environmental policies in China have curbed supply and added cost pressures for producers.”

The issue of supply is potentially a long-term price driver as China is the largest producer of tungsten globally, accounting for more than 80% of supply of tungsten concentrates in 2017.

A tightening in environmental restrictions has impacted the supply of many metals mined in China, with coal being severely impacted in recent years due to both environmental and mine safety issues.

Roskill reported that China’s Ministry of Ecology and Environment had flagged a second round of central environmental inspections across all provinces within the next three years, an initiative that could result in either mine closures or the instigation of compliance demands that would result in increased costs of production.

This could potentially render some mines uneconomical, prompting the need for the manufacturing giant to source tungsten from overseas producers.

Such a scenario where supply is constrained and demand increases should theoretically drive up prices.

Shining the spotlight on three ASX listed tungsten plays, it certainly appears that these stocks could be in the early stages of a recovery, and indeed in some cases recent developments have been transformational.

Apollo Minerals to recommence high-grade Salau mine

Reuters reported that shares in metals miner Apollo Minerals rose as much as 40% to 14 cents on Monday, representing its best day in more than two years.

This came on the back of the company receiving approval to reinstall mine services at its high-grade Salau tungsten mine in France.

Management has already shortlisted preferred drilling contractors for the initial underground drilling program at Salau designed to confirm known zones of tungsten mineralisation and test for extensions of these zones as a precursor to estimation and reporting of a Mineral Resource Estimate in accordance with the JORC Code.

Discussing the significance of this development and in particular referring to the company’s potential to supply nearby markets, Apollo’s Executive Director, Hugo Schumann said, “The Salau mine has the potential to create significant jobs in the Ariege department and to provide a strategic supply of tungsten to French industrial companies who currently rely on China for most of its supply of this critical raw material.”

King Island Scheelite gains most in over 5 years

In another recent development, Reuters reported that shares in tungsten explorer King Island Scheelite increased as much as 50% to 9.8 cents, their biggest intraday gain since September 5, 2013.

This occurred after the company executed an off-take agreement with Austria's Wolfram Bergbau und Hutten AG, a leading global supplier of tungsten powders based in Austria.

The group is a unit of Sweden-based engineering group Sandvik AB.

The agreement entails delivery of 140,000 metric tonne units of tungsten trioxide over a four-year period from the company’s revamped Dolphin mine in Tasmania

Wolfram uses the tungsten powders in manufacturing tech components for a range of industries including aerospace, energy and mining.

The company’s shares spiked under heavy volumes rarely seen with investors possibly also buoyed by news that further offtake contracts with other producers were at an advanced stage of negotiations.

Management noted that at full production the redeveloped Dolphin mine is expected to produce approximately 2000 tonnes of tungsten trioxide contained in 3100 tonnes of concentrate.

This indicates that the Wolfram agreement represents approximately 20% of the group’s annual production.

Production imminent at Specialty Metals’ Mt Carbine mine

From, the far south to the far north Speciality Metals International Ltd (ASX:SEI) is drawing closer to completing financing arrangements for its Mount Carbine tungsten project in North Queensland, a development which could see it in production as early as June 2019.

Cronimet Holding GmbH’s participation in the staged development of the Mt Carbine Tungsten Project and the purchase of the Mt Carbine Quarry and Mining Leases, ML4867 and ML4919, through alternative financial instruments is an important development for Specialty Metals.

With CRONIMET’s due diligence on the Mt Carbine Tungsten Project nearing completion, the contractual arrangements associated with its participation in the staged development of this project are in the process of being finalised.

Speciality Metals has also received confirmation from CRONIMET that the crushing, tabling and assay results for the test work carried out on the tailings material and stockpiled crushed rock have been finalised and the results are in the process of being interpreted by their technical team.

Some additional ultra-fine recovery test work will complete this segment of CRONIMET’s due diligence.

In anticipation of completion of the financing arrangements, Speciality Metals has commenced work on the refurbishment of the Mt Carbine Retreatment Plant.

One of the company’s former plant manager’s will assist CRONIMET’s process engineer and metallurgist with on-site assessment.

This is being completed to support a later redesign of the Retreatment Plant, in order to accommodate the latest reclaim technology.

Commenting on a potential transition to production date, executive chairman Russell Krause said, “Speciality Metals and CRONIMET are committed to finalising these arrangements within the shortest possible timeframe and whilst they are taking a little longer than initially anticipated, both parties are still aiming to be in production by the end of the first half of 2019.”

Shares in Specialty Metals increased three-fold between December and March, and they continue to trade not far shy of the 12 month high of the recent record closing price of 3.4 cents.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X